Pete Stavropoulos

Stock Analyst at Cantor Fitzgerald

(0)
# 4451
Out of 5,297 analysts
49
Total ratings
21.74%
Success rate
-14.47%
Average return
Main Sectors:
Top Industries:
14 Stocks
Name Action Price Target Current % Upside Ratings Updated
VYGR Voyager Therapeutics
Reiterates: Overweight
n/a
n/a n/a 2 Mar 12, 2025
ARCT Arcturus Therapeutic...
Reiterates: Overweight
n/a
n/a n/a 6 Mar 7, 2025
PLRX Pliant Therapeutics
Reinstates: Neutral
n/a
n/a n/a 5 Mar 4, 2025
KALV KalVista Pharma
Reiterates: Overweight
n/a
n/a n/a 1 Dec 9, 2024
ALEC Alector
Reiterates: Overweight
n/a
n/a n/a 5 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 9 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 1 Oct 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
107 107
23.58 353.77% 7 Oct 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
n/a
n/a n/a 1 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 4 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
5
3.03 65.02% 3 Sep 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
13
1.07 1114.95% 2 Jul 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
15
n/a n/a 2 Jun 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
8
6.71 19.23% 1 Mar 20, 2023